Compare Cassava Sciences Inc (FLNA) vs SpaceX (SPCX) Price & Performance

Cassava Sciences IncTrade

SpaceXTrade

Price performance (Past 24H)

Key statistics

Cassava Sciences Inc vs SpaceX — how do they compare? Cassava Sciences Inc trades at $0.95 (market cap $47.75M), while SpaceX trades at $145.88 (market cap $1.76T). The key difference: SpaceX is far larger — about 36858.6× Cassava Sciences Inc's market cap, and SpaceX is trading nearer its 52-week high, Cassava Sciences Inc nearer its low. Which is the better fit depends on your goals.

	FLNA	SPCX
Market Cap	$47.75M	$1.76T
Sector	Health	Technology
52-Week High	$4.64	$202.09
52-Week Low	$0.87	$108.27
Enterprise Value	-$34.93M	$1.70T

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Cassava Sciences Inc

FLNA trades at $0.9528, down 4.46% today, with a bearish technical outlook but strong analyst support (66.7% buy ratings). The company continues to post net losses and negative cash flows, though recent EPS beats show some operational improvement. Recent news highlights Q2 2026 results and business updates on Tuberous Sclerosis Complex therapies.

The outlook remains speculative due to persistent unprofitability and cash burn, but analyst optimism and a low P/B ratio of 0.75 may attract value investors. Key risks include execution challenges in drug development and reliance on financing amid negative earnings.

SpaceX

No Aura AI signal available yet.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

FLNA

View details →

SPCX

SpaceX and Intuitive Machines stocks rise ahead of earnings on strong satellite launches and new contracts.24/7 Wall Street · 5 hours agoBullish Norway's sovereign fund reveals $1.2B stake in SpaceX as stock nears IPO price.Finbold · 7 hours agoBullish SpaceX shares rebound near IPO price amid ambitious $1T revenue goal by 2030, but timeline seen as aggressive.24/7 Wall Street · 8 hours agoBullish View details →

About Cassava Sciences Inc

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease

About SpaceX

SpaceX is the world's leading aerospace manufacturer and launch provider. It designs and operates reusable rockets, spacecraft, and Starlink, a global satellite internet service with over 10 million subscribers across 160 countries.